ACCELERATING
THE NEXT
FRONTIER OF
INNOVATION
We invest in
frontier technology companies that use innovative science and deep technology to address some of the world’s most pressing challenges.
From fighting climate change to treating disease to meeting the world’s insatiable demand for compute, these challenges need urgent answers.
Addressing them will require bold, technical solutions that work on a massive scale -- creating the next trillion dollar opportunities.
These contrarian solutions may seem crazy today but will feel obvious in hindsight.
That’s why we’re investing at the frontier and supporting entrepreneurs as they build the companies that will define new categories and drive the next revolutions.
From fighting climate change to treating disease to meeting the world’s insatiable demand for compute, these challenges need urgent answers.
Addressing them will require bold, technical solutions that work on a massive scale -- creating the next trillion dollar opportunities.
These contrarian solutions may seem crazy today but will feel obvious in hindsight.
That’s why we’re investing at the frontier and supporting entrepreneurs as they build the companies that will define new categories and drive the next revolutions.
From fighting climate change to treating disease to meeting the world’s insatiable demand for compute, these challenges need urgent answers.
Addressing them will require bold, technical solutions that work on a massive scale -- creating the next trillion dollar opportunities.
These contrarian solutions may seem crazy today but will feel obvious in hindsight.
That’s why we’re investing at the frontier and supporting entrepreneurs as they build the companies that will define new categories and drive the next revolutions.
From fighting climate change to treating disease to meeting the world’s insatiable demand for compute, these challenges need urgent answers.
Addressing them will require bold, technical solutions that work on a massive scale -- creating the next trillion dollar opportunities.
These contrarian solutions may seem crazy today but will feel obvious in hindsight.
That’s why we’re investing at the frontier and supporting entrepreneurs as they build the companies that will define new categories and drive the next revolutions.
We invest in frontier technology companies that use innovative, science-based and deep technology to address some of the world’s most pressing challenges.
From fighting climate change to treating disease to meeting the world’s insatiable demand for compute, these challenges need urgent answers.
Addressing them will require bold, technical solutions that work on a massive scale -- creating the next trillion dollar opportunities.
These contrarian solutions may seem crazy today but will feel obvious in hindsight.
That’s why we’re investing at the frontier and supporting entrepreneurs as they build the companies that will define new categories and drive the next revolutions.
We invest in innovative, science-based and deep technology companies addressing some of the world’s most pressing challenges — from fighting climate change to finding cures for untreatable diseases to feeding the global population.
These challenges need urgent answers and solving them will create the next trillion dollar opportunities.
The solutions to today’s challenges won’t look like yesterday’s.
Software alone will only get us so far.
Addressing our most entrenched problems will take deeply technical innovations that work on a massive scale.
These contrarian solutions may seem crazy today but will feel obvious in hindsight.
That’s why we’re investing at the frontier and supporting entrepreneurs as they build the companies that will define new categories and drive the next revolutions.
FOCUS AREAS
The rate of change in life sciences is the greatest it's ever been because of advances in data generation coupled with AI and other computational techniques.
We believe biology is a toolset that can redesign the world around us, whether it's improving human health or mitigating climate change.
DIGITAL + BIO
We’re not interested in incrementalism. Building a massively impactful hardware company requires step-change improvements.
The rise of rapid prototyping, more advanced computer simulation, and ubiquitous AI/ML are just the start of the boundless opportunities technology has to reshape the physical world.
10X
HARDWARE
CLIMATE &
SUSTAINABILITY
Sustainability is table stakes in today's world where planetary health and human health are inextricably tied. This philosophy cuts across all of our investment themes and is at the core of our world view.
The agricultural system is under immense pressure from the demands of the growing global middle class, climate change, labor shortages, and complex, long-distance supply chains.
We believe the only way to solve these challenges is through the commercialization of ambitious full-stack technology solutions.
FOOD & AGRICULTURE
We need new technologies to make the world a smaller place – from moving people and goods to seamlessly and intuitively communicating with friends and family across the globe. All this must be done while eliminating the massive environmental impact caused by transportation today.
CONNECTIVITY:
DIGITAL & PHYSICAL
CLIMATE & SUSTAINABILITY
Sustainability is table stakes in today's world where planetary health and human health are inextricably tied. This philosophy cuts across all of our investment themes and is at the core of our world view.
PORTFOLIO
COMPANIES
.svg)
Ben and Tom are highly experienced and exceptionally talented investors who were strongly committed to the success of Schrodinger and who provided invaluable advice that helped the company excel and grow.
Ramy Farid
Ramy Farid
CEO of Schrodinger
Tom’s unique combination of technical background and investing acumen was a major asset for Ginkgo. He was a valuable voice in the board room that was both supportive and constructive.
Jason Kelly
Jason Kelly
CEO of Ginkgo Bioworks
Juvena is proud to be partnered with Bison Ventures. Bison’s experience and passion for using innovative science and technology to accelerate the discovery and development of novel therapeutics makes them an ideal partner for us.
Hanadie Yousef
Hanadie Yousef
CEO of Juvena Therapeutics
